600518 logo

Kangmei Pharmaceutical Co., Ltd. Stock Price

SHSE:600518 Community·CN¥24.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

600518 Share Price Performance

CN¥1.75
-0.15 (-7.89%)
CN¥1.75
-0.15 (-7.89%)
Price CN¥1.75

600518 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with very low risk.

2 Risks
0 Rewards

Kangmei Pharmaceutical Co., Ltd. Key Details

CN¥5.3b

Revenue

CN¥4.4b

Cost of Revenue

CN¥859.9m

Gross Profit

CN¥843.2m

Other Expenses

CN¥16.6m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 18, 2026
0.0012
16.30%
0.32%
0.2%
View Full Analysis

About 600518

Founded
1997
Employees
4233
CEO
Guoxiong Ou
WebsiteView website
www.kangmei.com.cn

Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China. The company offers Chinese patent medicines, chemical medicines, and health food products. In addition, it engages in the operation of Chinese medicinal materials markets; production and sale of medical devices; and operation of pharmaceutical logistics system. The company provides its products through medical institution resources, smart pharmacies, OTC retail, chain drug stores, direct sales, medical e-commerce, mobile medical care, etc. Kangmei Pharmaceutical Co., Ltd. was founded in 1997 and is based in Shenzhen, China.

Recent 600518 News & Updates

Recent updates

No updates